Omnicell Inc (OMCL)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ
Market Cap: $1.61B
Last updated: Nov 17, 2026 at 11:06 AM ET
Omnicell Inc (OMCL) Stock Forecast
Analysts expect Omnicell (OMCL) to earn $2.48 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.23B. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $2.01.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 12.5% |
| Buy | 6 | 75.0% |
| Hold | 1 | 12.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 19.0% and revenue estimates rise 0.8%.
- Fiscal year ending Dec 31, 2026
- $2.48
- EPS consensus, revenue $1.23B
- Fiscal year ending Dec 31, 2027
- $2.01
- EPS consensus, revenue $1.24B
- Next report
- Feb 3, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.48 | $2.45 to $2.52 | 8 | $1.23B | $1.23B to $1.23B | 8 |
| Dec 31, 2027 | $2.01 | $1.59 to $2.41 | 8 | $1.24B | $1.23B to $1.25B | 8 |
Quarterly Estimates
The EPS consensus rises from $0.39 for the quarter ending Dec 31, 2026 to $0.45 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.39 | $0.14 to $0.45 | 10 | $304.53M | $290.52M to $315.95M | 10 |
| Mar 31, 2027 | $0.45 | $0.33 to $0.62 | 7 | $304.51M | $298.92M to $312.02M | 7 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 7 upward and 8 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 3 | 5 |
| Quarter ending Mar 31, 2027 | 4 | 3 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 8.8% from $2.28.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.48 | $2.28 | $2.28 | $2.28 | $2.28 | +8.7% |
| Fiscal year ending Dec 31, 2027 | $2.01 | $2.06 | $2.09 | $2.09 | $2.09 | -3.9% |
| Quarter ending Mar 31, 2027 | $0.45 | $0.44 | $0.44 | $0.44 | $0.44 | +2.3% |
Frequently Asked Questions About OMCL
What is the OMCL stock forecast?
Consensus analyst estimates put Omnicell's EPS at $2.48 for the fiscal year ending Dec 31, 2026, on revenue of $1.23B. The consensus rating from 8 analysts is Buy.
How do analysts rate OMCL stock?
Of 8 analysts covering Omnicell, 1 rates it Strong Buy, 6 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from OMCL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.48, with estimates from $2.45 to $2.52 from 8 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.01, with estimates from $1.59 to $2.41 from 8 analysts.
What revenue do analysts expect from Omnicell next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.23B, with estimates from $1.23B to $1.23B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.24B, with estimates from $1.23B to $1.25B.
How many analysts cover OMCL?
8 analysts rate Omnicell stock, and 8 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
OMCL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts